TRIMTECH Therapeutics
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
$47MSeed+
Role not disclosedCE
Cambridge Enterprise Ventures
Activity from announced rounds
Activity in this selectionEurope · Seed
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $54.2M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionxWatts
Develops AI-driven energy management software to optimize energy use in real estate portfolios
£1.6MSeed
Role not disclosedSparxell
Sparxell makes plant-based pigments whose microscopic structure creates colour without conventional synthetic dyes.
$5MPre-Series A
Participant